David E. Greenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David E. Greenberg has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Steven M. Holland
3 shared publicationsAdrian M. Zelazny
2 shared publicationsFrida Stock
2 shared publications- Kol A. Zarember
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
2 shared publications Patrick R. Murray
2 shared publicationsStephen F. Porcella
2 shared publications
Latest Publications
- Open Access
- 1 September 2010
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (9) , 1341-1348
Recurrent Granulibacter bethesdensis Infections and Chronic Granulomatous Disease
Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from North and Central America. Genomic typing showed that 3 patients had recurrent infection months to years after apparent clinical cure. Two patients were infected with the same strain as previously isolated, and 1 was infected with a genetically distinct strain. This organism is multidrug resistant, and therapy required surgery and combination antimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.
- 1 September 2010
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (9) , 1341-1348
Open AccessRecurrent Granulibacter bethesdensis Infections and Chronic Granulomatous Disease
Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from North and Central America. Genomic typing showed that 3 patients had recurrent infection months to years after apparent clinical cure. Two patients were infected with the same strain as previously isolated, and 1 was infected with a genetically distinct strain. This organism is multidrug resistant, and therapy required surgery and combination antimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.
- Open Access
- 15 June 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (12) , 1822-1830
Antisense Phosphorodiamidate Morpholino Oligomers Targeted to an Essential Gene InhibitBurkholderia cepaciaComplex
(See the editorial commentary by Wiersinga, on pages 1786–1787.)Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbi
- 15 June 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (12) , 1822-1830
Open AccessAntisense Phosphorodiamidate Morpholino Oligomers Targeted to an Essential Gene InhibitBurkholderia cepaciaComplex
(See the editorial commentary by Wiersinga, on pages 1786–1787.)Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbi
- 9 February 2010
- Published by Taylor & Francis in Future Microbiology
- Vol. 5 (2) , 205-219
Host–Microbe Interaction Systems Biology: Lifecycle Transcriptomics and Comparative Genomics
The use of microarray and comparative genomic technologies for the analysis of host–pathogen interactions has led to a greater understanding of the biological systems involved in infectious disease...
- 9 February 2010
- Published by Taylor & Francis in Future Microbiology
- Vol. 5 (2) , 205-219
Host–Microbe Interaction Systems Biology: Lifecycle Transcriptomics and Comparative Genomics
The use of microarray and comparative genomic technologies for the analysis of host–pathogen interactions has led to a greater understanding of the biological systems involved in infectious disease...
- 1 November 2006
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 56 (11) , 2609-2616
Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae
A Gram-negative, aerobic, coccobacillus to rod-shaped bacterium was isolated from three patients with chronic granulomatous disease. The organism was subjected to a polyphasic taxonomic study. A multilocus phylogenetic analysis based on the 16S rRNA gene, the internal transcribed spacer (ITS) region and the RecA protein demonstrated that the organism belongs to a new sublineage within the acetic acid bacteria in the familyAcetobacteraceae. Phenotypic features are summarized as follows: the organism grew at an optimum temperature of 35–37 °C and optimum pH of 5.0–6.5. It produced a yellow pigment, oxidized lactate and acetate, the latter weakly, produced little acetic acid from ethanol and could use methanol as a sole carbon source. The two major fatty acids were a straight-chain unsaturated acid (C18 : 1ω7c) and C16 : 0. The DNA base composition was 59.1 mol% G+C. The very weak production of acetic acid from ethanol, the ability to use methanol, the yellow pigmentation and high optimum temperature for growth distinguished this organism from other acetic acid bacteria. The unique phylogenetic and phenotypic characteristics suggest that the bacterium should be classified within a separate genus, for which the nameGranulibacter bethesdensisgen. nov., sp. nov. is proposed. The type strain is CGDNIH1T(=ATCC BAA-1260T=DSM 17861T).
- 1 November 2006
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 56 (11) , 2609-2616
Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae
A Gram-negative, aerobic, coccobacillus to rod-shaped bacterium was isolated from three patients with chronic granulomatous disease. The organism was subjected to a polyphasic taxonomic study. A multilocus phylogenetic analysis based on the 16S rRNA gene, the internal transcribed spacer (ITS) region and the RecA protein demonstrated that the organism belongs to a new sublineage within the acetic acid bacteria in the familyAcetobacteraceae. Phenotypic features are summarized as follows: the organism grew at an optimum temperature of 35–37 °C and optimum pH of 5.0–6.5. It produced a yellow pigment, oxidized lactate and acetate, the latter weakly, produced little acetic acid from ethanol and could use methanol as a sole carbon source. The two major fatty acids were a straight-chain unsaturated acid (C18 : 1ω7c) and C16 : 0. The DNA base composition was 59.1 mol% G+C. The very weak production of acetic acid from ethanol, the ability to use methanol, the yellow pigmentation and high optimum temperature for growth distinguished this organism from other acetic acid bacteria. The unique phylogenetic and phenotypic characteristics suggest that the bacterium should be classified within a separate genus, for which the nameGranulibacter bethesdensisgen. nov., sp. nov. is proposed. The type strain is CGDNIH1T(=ATCC BAA-1260T=DSM 17861T).